ROCKEFELLER CAPITAL MANAGEMENT L.P. – Abiomed, Inc. Transaction History
ROCKEFELLER CAPITAL MANAGEMENT L.P. portfolio value:
$23.15M
portfolio value
ROCKEFELLER CAPITAL MANAGEMENT L.P. quarter portfolio value change:
-0.75%
quarter
Abiomed, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.12% | -1.06K shares | -439K | $245.66 | 94.25K |
Q2 2022 | share | Decrease | -1.14% | -1.10K shares | -8.34M | $247.51 | 95.31K |
Q1 2022 | share | Increase | +0.68% | 653 shares | -2.45M | $331.24 | 96.42K |
Q4 2021 | share | Increase | +0.16% | 153 shares | 3.27M | $362.06 | 95.76K |
Q3 2021 | share | Decrease | -0.02% | -16 shares | 1.27M | $325.52 | 95.61K |
Q2 2021 | share | Decrease | -3.11% | -3.06K shares | -1.61M | $312.11 | 95.63K |
Q1 2021 | share | Decrease | -1.10% | -1.09K shares | -895K | $318.73 | 98.7K |
Q4 2020 | share | Decrease | -2.86% | -2.93K shares | 3.89M | $324.2 | 99.79K |
Q3 2020 | share | Decrease | -1.02% | -1.05K shares | 3.39M | $277.06 | 102.73K |
Q2 2020 | share | Increase | +0.09% | 96 shares | 10.01M | $241.56 | 103.79K |
Q1 2020 | share | Increase | +0.67% | 691 shares | -2.51M | $145.16 | 103.69K |
Q4 2019 | share | Increase | +1.71% | 1.73K shares | -444K | $170.59 | 103.00K |
Q3 2019 | share | Increase | +5.18% | 4.98K shares | -7.06M | $177.89 | 101.27K |
Q2 2019 | share | Decrease | -1.30% | -1.26K shares | -2.77M | $260.49 | 96.28K |
Q1 2019 | share | Decrease | -3.96% | -4.02K shares | -5.15M | $285.59 | 97.55K |
Q4 2018 | share | Decrease | -2.03% | -2.10K shares | -13.61M | $325.04 | 101.57K |
Q3 2018 | share | Decrease | -3.78% | -4.07K shares | 2.55M | $449.75 | 103.68K |
Q2 2018 | share | Decrease | -22.21% | -30.76K shares | 3.77M | $409.05 | 107.75K |
Q1 2018 | share | Increase | 0.00% | 138.51K shares | 40.30M | $290.99 | 138.51K |